These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 10902629

  • 1. Oral contraceptives and fatal pulmonary embolism.
    Parkin L, Skegg DC, Wilson M, Herbison GP, Paul C.
    Lancet; 2000 Jun 17; 355(9221):2133-4. PubMed ID: 10902629
    [Abstract] [Full Text] [Related]

  • 2. Risk of fatal pulmonary embolism with oral contraceptives.
    Poulter NR.
    Lancet; 2000 Jun 17; 355(9221):2088. PubMed ID: 10902616
    [Abstract] [Full Text] [Related]

  • 3. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep 17; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M, Mann J, Murphy M, Vessey M.
    Int J Epidemiol; 1992 Feb 17; 21(1):48-52. PubMed ID: 1544757
    [Abstract] [Full Text] [Related]

  • 5. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ.
    Contraception; 1998 Feb 17; 57(2):67-70. PubMed ID: 9589831
    [Abstract] [Full Text] [Related]

  • 6. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH.
    Lancet; 1996 Oct 12; 348(9033):983-7. PubMed ID: 8855854
    [Abstract] [Full Text] [Related]

  • 7. Oral contraceptives and venous thromboembolism: a case-control study designed to minimize detection bias.
    Realini JP, Encarnacion CE, Chintapalli KN, Rees CR.
    J Am Board Fam Pract; 1997 Oct 12; 10(5):315-21. PubMed ID: 9297655
    [Abstract] [Full Text] [Related]

  • 8. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct 12; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of oral contraceptives: a review.
    Stubblefield PG.
    Int J Fertil; 1989 Oct 12; 34 Suppl():40-9. PubMed ID: 2576258
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr 26; 349(9060):1202-9. PubMed ID: 9130941
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Oral contraceptives and cardiovascular diseases morbidity].
    Lara Ricalde R, Aznar Ramos R.
    Ginecol Obstet Mex; 1986 May 26; 54():119-25. PubMed ID: 3732840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG, Tonascia J, Sartwell PE, Stolley PD, Tockman MS.
    Am J Epidemiol; 1979 Aug 26; 110(2):188-95. PubMed ID: 463873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Vascular disease and hormonal treatment--epidemiology].
    Vessey MP.
    Contracept Fertil Sex (Paris); 1985 Jan 26; 13(1 Suppl):121-6. PubMed ID: 12280197
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.